Viramune^®

For the combination therapy of HIV-1 infection and (in several countries) for the prevention of mother-to-child transmission of HIV-1 in pregnant women who are not taking antiretroviral therapy at time of labour.
Prolonged release tablets for once-daily dosing within combination therapy.